Recent results obtained in our laboratory demonstrate unequivocally that the selection of influenza viruses to grow in primary chick kidney cells (PCKC) at suboptimal temperature (25 °C) is a practical means for obtaining attenuated viruses for use as vaccine. The derived 'cold variants' of types A and B influenza virus were shown to be attenuated for animals and man (Maassab, 1969; Maassab et al. 1969; Beare et al. 1971). More recently a 'cold variant' of respiratory syncytial virus was selected to grow at 25 °C in a diploid cell line (WI-38) with characteristics comparable to cold variants of influenza viruses (H. F. Maassab, in preparation). This study was initiated in order to apply similar methods to the selection of a DNA virus such as herpes simplex virus to grow at suboptimal temperature (25 °C) in PCKC. The procedure employed yielded reproducible results when three major conditions were met: vigorous growth of virus at suboptimal temperature, production of cytopathic changes at 25 °C and efficient formation of plaques. It was then possible to assess the extent to which selected' cold variants' differed in virulence from that of the initial virus population when inoculated into susceptible mice.
. The responses of mice to infection with each selected cold variant of herpesvirus is presented in Table z . The same cold variant pools and original strains of types I and 2 were titrated in mice and PCKC monolayers incubated at 35 °C. The derived cold variants of herpes simplex virus were attenuated and immunogenic for mice when inoculated intracerebrally. Typical results show that the 'original' strains of either type were highly neurovirulent with type I showing I6 p.f.u./LDso and type 2, 3 P.f.u-/LDso-A comparison of the infectivities for the cold-selected strains shows that for type I some attenuation 0o 3.3 p.f.u./ LDs0) was evident. However, the most striking finding was the selection of an avirulent cold variant of type 2 herpesvirus with > io 6"2 p.f.u./LDs0. Hence, in this case, the cold-selection of a DNA virus yielded a variant population which was temperature sensitive in plaque formation and avirulent for mice.
The response of mice to two different pools of the selected cold variant of type 2 and the subsequent challenge of these mice with its virulent original strain is shown in Table 3 . Mice inoculated with varying doses of the cold variant were clearly protected against intracerebral challenge by IOO MLDs0 of the virulent parent strain.
